bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
8.50
-0.73 (-7.91%)
At close: Dec 20, 2024, 4:00 PM
8.39
-0.11 (-1.29%)
After-hours: Dec 20, 2024, 5:59 PM EST

bluebird bio Revenue

bluebird bio had revenue of $10.61M in the quarter ending September 30, 2024, a decrease of -14.36%. This brings the company's revenue in the last twelve months to $53.12M, up 144.50% year-over-year. In the year 2023, bluebird bio had annual revenue of $29.50M with 720.04% growth.

Revenue (ttm)
$53.12M
Revenue Growth
+144.50%
P/S Ratio
1.40
Revenue / Employee
$141,653
Employees
375
Market Cap
82.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202329.50M25.90M720.04%
Dec 31, 20223.60M-65.00K-1.77%
Dec 31, 20213.66M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
23andMe Holding Co. 193.26M
Karyopharm Therapeutics 148.44M
Assertio Holdings 125.76M
EDAP TMS 70.72M
Aadi Bioscience 25.07M
Adlai Nortye 5.00M
Revenue Rankings